Abstract:OBJECTIVE:To identify the differentially expressed proteins or peptides and potential biomarkers of tumorigenesis for colorectal cancers.METHODS:Immobilized pH gradient two-dimensional gel electrophoresis (2-DE) was used to separate and obtain the differentially expressed protein spots between colorectal cancers and matched normal mucosa. Liquid chromatography/mass spectrometry (LC-MS/MS) was used to characterize these proteins. Selected candidate proteins were further studied by Western blot, semi-quantitative RT-PCR and immunohistochemical staining.RESULTS:Thirty-five protein spots showed marked expression changes (more than 5-fold) in colorectal carcinoma compared to normal mucosa. Fifteen proteins were up regulated and 20 were down regulated. Fourteen of these proteins were identified by tandem mass spectrometry, among which secretagogin (SCGN) was down-regulated and glucose-related protein (GRP) 78 was up-regulated in the tumors. The SCGN down-regulation was further supported by Western blot and RT-PCR analyses. Immunohistochemistry revealed that SCGN was strongly expressed in neuroendocrine cells of the colonic crypts and 53 of 54 (98%) neuroendocrine tumors. At protein level, although GRP78 was up regulated in colorectal carcinoma, there was no difference in the mRNA expression level between the tumor and paired normal mucosa.CONCLUSIONS:The 2-DE combined with MS is a powerful tool for screening potential tumor biomarkers. The differentially expressed candidate proteins identified by 2-DE may be of significance in understanding the tumorigenesis of the colon cancer. SCGN is a potential biomarker for neuroendocrinal differentiation. GRP78 up-regulation in colorectal carcinomas may be related to its post-translational modification.

Screening and Identification of Differential Expression Proteins from Pancreatic Carcinoma and Neighboring Normal Pancreatic Tissues

Differential analysis of two-dimensional gel electrophoresis profile of pancreatic ductal adenocarcinoma and adjacent tissue

Differential Expressed Profile of Proteins in Normal Tissue and Pancreatic Cancer Using Proteomic Approaches

Screening Serum Biomarkers for Pancreatic Cancer by Serum Proteomics Techniques

Differential Proteome Profiling of Pleural Effusions from Lung Cancer and Benign Inflammatory Disease Patients

Proteomics Analysis of Serum Protein Profiling in Pancreatic Cancer Patients by DIGE: Up-Regulation of Mannose-Binding Lectin 2 and Myosin Light Chain Kinase 2

Identification of Proteins Implicated in the Development of Pancreatic Cancer-Associated Diabetes Mellitus by Itraq-Based Quantitative Proteomics.

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

Proteome and secretome analysis of pancreatic cancer cells

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

Gene Expression Profiles in Primary Pancreatic Tumors and Metastatic Lesions of Ela-c-myc Transgenic Mice

[Differential Expression of Secretagogin and Glucose-Related Protein 78 in Colorectal Carcinoma: a Proteome Study].

Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers.

Identification of Differentially Expressed Proteins in Colorectal Cancer by Proteomics: Down-regulation of Secretagogin

Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis

Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer

Screening for Protein Markers from Serum of Patients with Pancreatic Carcinoma by Protein Finger Printing Technique

Differential proteomic research on golden hamster pancreatic cancer model

Diferential analysis of two-dimensional gel electrophoresis profiles for oral squamous cell carcinoma.

Benchmark of site- and structure-specific quantitative tissue N-glycoproteomics for discovery of potential N-glycoprotein markers: a case study of pancreatic cancer

Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines